Genomics

Tailoring medication selection with pharmacogenomic testing

April 1, 2024 - In modern healthcare, pharmacogenomic assessments are helping healthcare providers determine medication selection, ensuring tailored treatment plans for everyone’s unique genetic makeup. Pharmacogenomic Testing Drug–gene testing, referred to as pharmacogenomics or pharmacogenetics, investigates how individual genetic makeup influences the body's response to drugs....


More Articles

Understanding Implications of Pharmacogenomic on Prescribing

by Veronica Salib

Pharmacogenomic research explores how specific genes or genetic variations can impact drug responses and treatment outcomes. While not a standard of care, pharmacogenomic testing can significantly impact prescribing and medication safety....

Phase 1 Clinical Trial Achieves Leukemia Remission in 18 Patients

by Veronica Salib

In a study published in Nature on March 15, 2023, researchers achieved complete or nearly complete remission in 18 patients with KMT2A-rearranged or NPMI-mutant leukemia. The phase 1 clinical trial...

Moderna to Buy Japanese Firm OriCiro in Its First-Ever Acquisition

by Hayden Schmidt

Moderna Inc and Japan-based OriCiro Genomics K.K. reached an agreement on Wednesday wherein Moderna will acquire OriCiro and its suite of biopharmaceutical applications for $85...

FDA Refuses to File Aeglea Biologics License Application

by Hayden Schmidt

Aeglea BioTherapuetics announced that it had failed to secure a biologics license application (BLA) from the FDA after administrators issued a refusal to file for the company’s biologic...

CRISPR Technology Detects COVID-19 From Respiratory RNA Extracts

by Samantha McGrail

The lack of rapid and accurate molecular diagnostic testing has impeded the healthcare system’s response to the COVID-19 pandemic. Recently, researchers developed rapid, easy-to-implement, and...

Graphics Processing Units Tech to Accelerate COVID-19 Sequencing

by Samantha McGrail

Genome-sequencing software NVIDIA announced that it will provide a free 90-day license to Parabricks to any researcher worldwide for rapid  COVID-19 sequencing, according to a recent press...